CUG-252
/ Cugene, AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
February 20, 2025
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=40 | Active, not recruiting | Sponsor: Cugene Inc. | Recruiting ➔ Active, not recruiting | Trial completion date: Jul 2024 ➔ Apr 2025 | Trial primary completion date: Jul 2024 ➔ Apr 2025
Enrollment closed • Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
February 20, 2025
A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=32 | Completed | Sponsor: Cugene Inc. | Active, not recruiting ➔ Completed
Trial completion • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
May 19, 2023
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Cugene Inc.
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
December 01, 2022
A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=32 | Active, not recruiting | Sponsor: Cugene Inc. | N=88 ➔ 32
Enrollment change • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
November 15, 2022
Study of CUG252 in Healthy Volunteers and in Patients With Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=88 | Active, not recruiting | Sponsor: Cugene Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
May 16, 2022
"Has the been any clinical data reported for the molecule (CUG252)?"
(@WSceptor)
Clinical data
April 14, 2022
Study of CUG252 in Healthy Volunteers and in Patients With Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=88 | Recruiting | Sponsor: Cugene Inc.
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
1 to 7
Of
7
Go to page
1